TuHURA BIOSCIENCES, INC./NV Unrealized Gain (Loss) on Derivatives
TuHURA BIOSCIENCES, INC./NV (HURA) reported Unrealized Gain (Loss) on Derivatives of $433.50 thousand for the 12-month period ending 2019-06-30, per its 10-K filed 2020-09-18.
Discontinued › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnDerivatives · last filed 2020-09-18
- TuHURA BIOSCIENCES, INC./NV unrealized gain (loss) on derivatives for the quarter ending 2019-06-30 was $432.65K, a 18942.74% increase year-over-year.
- TuHURA BIOSCIENCES, INC./NV unrealized gain (loss) on derivatives for the quarter ending 2019-03-31 was -$189.00, a 108.75% decline year-over-year.
- TuHURA BIOSCIENCES, INC./NV unrealized gain (loss) on derivatives for the quarter ending 2018-12-31 was $1.26K.
- TuHURA BIOSCIENCES, INC./NV unrealized gain (loss) on derivatives for the quarter ending 2018-09-30 was -$220.00, a 100.39% decline year-over-year.
- TuHURA BIOSCIENCES, INC./NV unrealized gain (loss) on derivatives for fiscal 2019 was $433.50K, a 621.17% increase from fiscal 2018.
- TuHURA BIOSCIENCES, INC./NV unrealized gain (loss) on derivatives for fiscal 2018 was $60.11K.
- TuHURA BIOSCIENCES, INC./NV unrealized gain (loss) on derivatives for fiscal 2016 was -$2.34M, a 473.21% decline from fiscal 2015.
- TuHURA BIOSCIENCES, INC./NV unrealized gain (loss) on derivatives for fiscal 2015 was $627.43K, a 94.56% decline from fiscal 2014.
| Period end | Unrealized Gain (Loss) on Derivatives 3 month | Unrealized Gain (Loss) on Derivatives 6 month | Unrealized Gain (Loss) on Derivatives 9 month | Unrealized Gain (Loss) on Derivatives 9 month as first filed | Unrealized Gain (Loss) on Derivatives 12 month | Unrealized Gain (Loss) on Derivatives 12 month as first filed |
|---|---|---|---|---|---|---|
| 2019-06-30 | $432.65K derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-18 | $432.46K derived: sum of 2 quarters · filed 2020-09-18 | $433.72K derived: sum of 3 quarters · filed 2020-09-18 | $433.50K 10-K · filed 2020-09-18 | ||
| 2019-03-31 | -$189.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-13 | $1.07K derived: sum of 2 quarters · filed 2020-05-13 | $852.00 10-Q · filed 2020-05-13 | $3.12K derived: sum of 4 quarters · filed 2020-05-13 | ||
| 2018-12-31 | $1.26K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-13 | $1.04K 10-Q · filed 2020-02-13 | $3.31K derived: sum of 3 quarters · filed 2020-02-13 | $5.47K derived: sum of 4 quarters · filed 2020-02-13 | ||
| 2018-09-30 | -$220.00 10-Q · filed 2019-11-13 | $2.05K derived: sum of 2 quarters · filed 2019-11-13 | $4.21K derived: sum of 3 quarters · filed 2019-11-13 | $3.32K derived: sum of 4 quarters · filed 2019-11-13 | ||
| 2018-06-30 | $2.27K derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-09 | $4.43K derived: sum of 2 quarters · filed 2019-09-09 | $3.54K derived: sum of 3 quarters · filed 2019-09-09 | $60.11K 10-K · filed 2019-09-09 | ||
| 2018-03-31 | $2.16K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-14 | $1.27K derived: sum of 2 quarters · filed 2019-05-14 | $57.84K 10-Q · filed 2019-05-14 | $245.30K derived: sum of 4 quarters · filed 2019-06-03 | ||
| 2017-12-31 | -$889.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-02-11 | $55.68K 10-Q · filed 2019-02-11 | $243.14K derived: sum of 3 quarters · filed 2019-06-03 | $165.66K derived: sum of 4 quarters · filed 2019-06-03 | ||
| 2017-09-30 | $56.57K 10-Q · filed 2018-11-13 | $244.03K derived: sum of 2 quarters · filed 2019-06-03 | $166.55K derived: sum of 3 quarters · filed 2019-06-03 | $528.22K derived: sum of 4 quarters · filed 2019-06-03 | ||
| 2017-06-30 | $187.46K derived: 8-K 12 month − 10-Q 9 month · filed 2019-06-03 | $109.98K derived: sum of 2 quarters · filed 2019-06-03 | $471.65K derived: sum of 3 quarters · filed 2019-06-03 | $245.96K 8-K · filed 2019-06-03 | ||
| 2017-03-31 | -$77.48K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-05-15 | $284.19K derived: sum of 2 quarters · filed 2018-05-15 | $58.50K 10-Q · filed 2018-05-15 | -$1.34M derived: sum of 4 quarters · filed 2018-05-15 | ||
| 2016-12-31 | $361.67K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-02-14 | $135.98K 10-Q · filed 2018-02-14 | -$1.26M derived: sum of 3 quarters · filed 2018-02-14 | -$986.05K derived: sum of 4 quarters · filed 2018-02-14 | ||
| 2016-09-30 | -$225.69K 10-Q · filed 2017-11-09 | -$1.62M derived: sum of 2 quarters · filed 2017-11-09 | -$1.35M derived: sum of 3 quarters · filed 2017-11-09 | -$2.03M derived: sum of 4 quarters · filed 2017-11-09 | ||
| 2016-06-30 | -$1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-27 | -$1.12M derived: sum of 2 quarters · filed 2017-09-27 | -$1.80M derived: sum of 3 quarters · filed 2017-09-27 | -$2.34M 10-K · filed 2017-09-27 | ||
| 2016-03-31 | $276.58K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-05-12 | -$403.60K derived: sum of 2 quarters · filed 2017-05-12 | -$943.05K 10-Q · filed 2017-05-12 | $136.18K derived: sum of 4 quarters · filed 2017-05-12 | ||
| 2015-12-31 | -$680.19K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-02-10 | -$1.22M 10-Q · filed 2017-02-10 | -$140.41K derived: sum of 3 quarters · filed 2017-02-10 | -$921.56K derived: sum of 4 quarters · filed 2017-02-10 | ||
| 2015-09-30 | -$539.45K 10-Q · filed 2016-11-10 | $539.78K derived: sum of 2 quarters · filed 2016-11-10 | -$241.37K derived: sum of 3 quarters · filed 2016-11-10 | $650.96K derived: sum of 4 quarters · filed 2016-11-10 | ||
| 2015-06-30 | $1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2016-09-13 | $298.07K derived: sum of 2 quarters · filed 2016-09-13 | $1.19M derived: sum of 3 quarters · filed 2016-09-13 | $627.43K 10-K · filed 2016-09-13 | $179.17K 10-K · filed 2015-09-03 | |
| 2015-03-31 | -$781.15K 10-Q · filed 2016-05-12 | $111.17K derived: sum of 2 quarters · filed 2016-05-12 | -$451.79K 10-Q · filed 2016-05-12 | -$276.96K 10-Q · filed 2015-05-15 | $4.21M derived: sum of 4 quarters · filed 2016-05-12 | |
| 2014-12-31 | $892.33K 10-Q · filed 2016-02-12 | $329.36K 10-Q · filed 2016-02-12 | $4.99M derived: sum of 3 quarters · filed 2016-02-12 | |||
| 2014-09-30 | -$562.97K 10-Q · filed 2015-11-16 | $4.10M derived: sum of 2 quarters · filed 2015-11-16 | ||||
| 2014-06-30 | $4.66M derived: 10-K 12 month − 10-Q 9 month · filed 2015-11-16 | $11.53M 10-K · filed 2015-11-16 | $8.30M 10-K · filed 2015-09-03 | |||
| 2014-03-31 | $6.87M 10-Q · filed 2015-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |